guidelines:
  1: NUTRIC_score_guideline.v1
test_cases:
- id: score 10
  input:
    1:
      gt0003|Age: 75,a
      gt0005|APACHE II: 3|local::at0012|≥28|
      gt0006|SOFA Score: 2|local::at0016|≥10|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 2|local::at0007|≥75|
      gt0012|NUTRIC Score: 10
      gt0013|Risk: High risk
      gt0031|Note: Consider aggressive nutrition therapy (enteral or parenteral).
      gt0014|28-day mortality: ~80%
- id: score 9
  input:
    1:
      gt0003|Age: 74,a
      gt0005|APACHE II: 3|local::at0012|≥28|
      gt0006|SOFA Score: 2|local::at0016|≥10|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 1|local::at0006|50–74|
      gt0012|NUTRIC Score: 9
      gt0013|Risk: High risk
      gt0031|Note: Consider aggressive nutrition therapy (enteral or parenteral).
      gt0014|28-day mortality: ~70%
- id: score 8
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 3|local::at0012|≥28|
      gt0006|SOFA Score: 2|local::at0016|≥10|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 8
      gt0013|Risk: High risk
      gt0031|Note: Consider aggressive nutrition therapy (enteral or parenteral).
      gt0014|28-day mortality: ~58%
- id: score 7
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 2|local::at0011|20-27|
      gt0006|SOFA Score: 2|local::at0016|≥10|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 7
      gt0013|Risk: High risk 
      gt0031|Note: Consider aggressive nutrition therapy (enteral or parenteral).
      gt0014|28-day mortality: ~45%
- id: score 6
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 1|local::at0010|15-19|
      gt0006|SOFA Score: 2|local::at0016|≥10|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 6
      gt0013|Risk: High risk 
      gt0031|Note: Consider aggressive nutrition therapy (enteral or parenteral).
      gt0014|28-day mortality: ~30%
- id: score 5
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 2|local::at0016|≥10|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 5
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~20%
- id: score 4
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 1|local::at0015|6-9|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 4
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~11%
- id: score 3
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 0|local::at0014|<6|
      gt0007|Number of comorbidities: 1|local::at0019|≥2|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 3
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~8%
- id: score 2
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 0|local::at0014|<6|
      gt0007|Number of comorbidities: 0|local::at0018|0-1|
      gt0008|Days in hospital to ICU admit: 1|local::at0022|≥1|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 2
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~3%
- id: score 1
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 0|local::at0014|<6|
      gt0007|Number of comorbidities: 0|local::at0018|0-1|
      gt0008|Days in hospital to ICU admit: 0|local::at0021|0|
      gt0009|IL-6 (µ/mL): 1|local::at0025|≥400|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 1
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~2%
- id: score 0
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 0|local::at0014|<6|
      gt0007|Number of comorbidities: 0|local::at0018|0-1|
      gt0008|Days in hospital to ICU admit: 0|local::at0021|0|
      gt0009|IL-6 (µ/mL): 0|local::at0024|0–399|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 0
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~1%
- id: score 0 without IL-6
  input:
    1:
      gt0003|Age: 49,a
      gt0005|APACHE II: 0|local::at0009|<15|
      gt0006|SOFA Score: 0|local::at0014|<6|
      gt0007|Number of comorbidities: 0|local::at0018|0-1|
      gt0008|Days in hospital to ICU admit: 0|local::at0021|0|
  expected_output:
    1:
      gt0011|Age, years: 0|local::at0005|<50|
      gt0012|NUTRIC Score: 0
      gt0013|Risk: Low risk
      gt0014|28-day mortality: ~1%
